The 9th China International Import Expo is now in full swing at the National Exhibition and Convention Center in Shanghai.

In NH’s Innovation Incubation Zone, one exhibit booth brings together the “hard power of synthetic chemistry” and the “soft intelligence of R&D data” on a single platform—

Ruichen Kangda Biopharmaceutical × Jianwei Software, Booth NA-09-59, looking forward to chatting with you.

I. Pharmaceutical Research Focused on Turning “Difficult-to-Develop Molecules” into Scalable Drugs

Ruichen Kangda Biopharmaceutical (Wuhan) is based in the Guanggu South Big Health Industrial Park, focusing on custom synthesis of innovative drug intermediates, process development for high-end generic drug APIs, and the synthesis of functional new materials.

From milligram-scale process development to lab‑scale, pilot‑scale, and kilogram‑scale scale‑up, and finally to industrial‑scale delivery, the team has embedded “green, efficient, and scalable” principles into every step of the process.

Telling a story without relying on concepts, letting the reaction vial do the talking:

Chiral building blocks, deuterated intermediates, and specialty heterocyclic compounds—custom-made to order.

Reverse-engineering process pain points to help pharmaceutical companies turn “lab‑scale feasibility” into “factory‑scale deliverability.”

It has completed tens of millions in angel funding, with its R&D platform and production lines being upgraded in parallel.

There are no shortcuts in pharmaceutical research, but there can be a more solid foundation.

II. Innovating the Future: Transforming R&D Data from “Footprint” to “Asset”

Jianwei Software (Hangzhou) focuses on another fundamental infrastructure in pharmaceutical research: the intelligent management of laboratory data and R&D workflows.

Targeting pharmaceutical R&D and testing scenarios, Jianwei leverages its capabilities in application software development and data asset management to help teams:

Samples, spectra, batches, process parameters, compliance records…

Consolidate data from disparate spreadsheets into AI data assets that are traceable, reusable, and trainable.

Let every synthesis attempt be recorded, and let every failed route feed back into the next success.

III. Why a “Joint Booth”?

Innovative drug development has never been about breakthroughs at a single point:

Molecules must be synthesized by someone.

The process needs someone to scale it up.

Data needs to be curated by people.

Someone has to propose the decision.

Ruichen Kangda is responsible for “building a solid foundation in chemistry,” while Jianwei Software is responsible for “turning experience into assets.”

The two companies shared a booth at NA-09-59, not competing for exhibition space but instead presenting a joint solution that combines “hard synthesis with soft data.”

 

IV. What Can We Talk About at the CIIE?

If you are from:

Innovative Pharmaceutical Companies / Biotechs: Custom Synthesis, Intermediate Supply, Process Development

CRO / Research Institutions: Scale-up from Lab to Production, Data Governance, Lightweight LIMS Implementation

Industrial Investment / Park Platform: Digital and Intelligent Biopharmaceutical Consortium Sample

Hospital Translational Center: Bridging Lead Compounds to Translational Processes

Come to our booth, and we can chat:

✅ Retrosynthetic analysis of challenging molecules

✅ Customized delivery of intermediates from 0 to 1

✅ R&D Data Assetization and Compliance Traceability

✅ Industry–Academia–Research Collaboration in the CIIE Context

V. Booth Information

📍 National Exhibition and Convention Center (Shanghai) · NH Pavilion Innovation Incubation Zone

📌 Booth Number: NA-09-59

🤝 Ruichen Kangda × Jianwei Software

🎯 Pharmaceutical Research Unites Strengths, Smart Innovation Shapes the Future

See you in Shanghai from November 5–10.

We’re not here to gawk; we’re here to get clear on the “next molecule.”

Pharmaceutical research joins forces, intelligent innovation shapes the future—We look forward to your visit to NA-09-59.